Paulina Reus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Paulina Reus has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Agata Filipowska
Poznań University of Economics and Business
1 shared publication - Agata Michnowska
Department of Immunological Diagnostics, Pomeranian Medical University, 70-204 Szczecin, Poland
1 shared publication - Bartosz Wojciuk
Department of Diagnostic Immunology, Chair of Microbiology, Immunology and Laboratory Medicine, Pomeranian Medical University in Szczecin, 72 Powstańców Wlkp. Al., 70-111 Szczecin, Poland
1 shared publication - Bartłomiej Grygorcewicz
Department of Genomics and Forensic Genetics, Faculty of Medicine, Pomeranian Medical University in Szczecin , Szczecin , Poland
1 shared publication - Karolina Kędzierska-Kapuza
Department of Internal Medicine, Endocrinology and Diabetology, National Medical Institute of the Ministry of Interior and Administration in Warsaw, 137 Wołoska Street, 02-507 Warsaw, Poland
1 shared publication - Kazimierz Ciechanowski
Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, Szczecin, Poland
1 shared publication
Latest Publications
- Open Access
Explorative Insights into Local Immune Response to BK Virus—A Cross-Sectional Study in Urine Samples Between Transplant Recipients and Non-Immunocompromised Hosts
Background and Objectives: BK virus (BKPyV) is a common latent pathogen in humans, but it becomes particularly insidious in kidney transplant recipients, where reactivation may contribute to allograft loss. The immune mechanisms controlling BKPyV latency in immunocompromised hosts remain incompletely understood. We assume the urinary immune proteome reflects local immune response in the kidney and the urinary tract. Thus, this study aimed to determine whether the presence of BKPyV alters the urinary immune-related proteomic profile of kidney transplant recipients and shifts it away to that observed in healthy individuals. Materials and Methods: 137 urine samples were collected from kidney recipients, both BKPyV-positive and BKPyV-negative, patients with stage 5 chronic kidney disease, and healthy controls. Targeted proteomic analysis was performed using the proximity extension assay, followed by heatmapping, principal component analysis, random forest, and linear regression modeling. Results: The urinary proteome of BKPyV-positive recipients remained more distinct from healthy controls than that of BKPyV-negative ones. Among the 33 proteins detected across all samples, 17 showed significant intergroup differences, with KLRD1 (CD94) uniquely upregulated in all transplant recipients, but downregulated in BKPyV-positive samples. Conclusions: We conclude that the presence of BKPyV in the urinary tract of kidney recipients notably interplays with the local immune response even in the absence of clinical disease.
Open AccessExplorative Insights into Local Immune Response to BK Virus—A Cross-Sectional Study in Urine Samples Between Transplant Recipients and Non-Immunocompromised Hosts
Background and Objectives: BK virus (BKPyV) is a common latent pathogen in humans, but it becomes particularly insidious in kidney transplant recipients, where reactivation may contribute to allograft loss. The immune mechanisms controlling BKPyV latency in immunocompromised hosts remain incompletely understood. We assume the urinary immune proteome reflects local immune response in the kidney and the urinary tract. Thus, this study aimed to determine whether the presence of BKPyV alters the urinary immune-related proteomic profile of kidney transplant recipients and shifts it away to that observed in healthy individuals. Materials and Methods: 137 urine samples were collected from kidney recipients, both BKPyV-positive and BKPyV-negative, patients with stage 5 chronic kidney disease, and healthy controls. Targeted proteomic analysis was performed using the proximity extension assay, followed by heatmapping, principal component analysis, random forest, and linear regression modeling. Results: The urinary proteome of BKPyV-positive recipients remained more distinct from healthy controls than that of BKPyV-negative ones. Among the 33 proteins detected across all samples, 17 showed significant intergroup differences, with KLRD1 (CD94) uniquely upregulated in all transplant recipients, but downregulated in BKPyV-positive samples. Conclusions: We conclude that the presence of BKPyV in the urinary tract of kidney recipients notably interplays with the local immune response even in the absence of clinical disease.